Experimental therapy of filovirus infections

被引:47
作者
Bray, M [1 ]
Paragas, J [1 ]
机构
[1] USA, Med Res Inst Infect Dis, Div Virol, Dept Viral Theapeut, Ft Detrick, MD 21702 USA
关键词
filovirus; Ebola virus; Marburg virus; antiviral therapy; S-adenosyl-L-homocysteine hydrolase; interferon-alpha;
D O I
10.1016/S0166-3542(02)00005-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 17
页数:17
相关论文
共 79 条
[1]   INTERFERON INDUCTION BY GLYCYRRHIZIN AND GLYCYRRHETINIC ACID IN MICE [J].
ABE, N ;
EBINA, T ;
ISHIDA, N .
MICROBIOLOGY AND IMMUNOLOGY, 1982, 26 (06) :535-539
[2]   Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy [J].
Adah, SA ;
Bayly, SF ;
Cramer, H ;
Silverman, RH ;
Torrence, PF .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (10) :1189-1212
[3]   ANTIVIRAL IMMUNOTOXINS - ANTIBODY-MEDIATED DELIVERY OF GELONIN INHIBITS PICHINDE VIRUS-REPLICATION INVITRO [J].
BARNETT, BB ;
BURNS, NJ ;
PARK, KJ ;
DAWSON, MI ;
KENDE, M ;
SIDWELL, RW .
ANTIVIRAL RESEARCH, 1991, 15 (02) :125-138
[4]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[5]   THE ASIALOGLYCOPROTEIN RECEPTOR IS A POTENTIAL LIVER-SPECIFIC RECEPTOR FOR MARBURG VIRUS [J].
BECKER, S ;
SPIESS, M ;
KLENK, HD .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :393-399
[6]   Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART [J].
Berger, EA ;
Moss, B ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11511-11513
[7]  
Borisevich IV, 1995, VOP VIRUSOL+, V40, P270
[8]   Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530
[9]   A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever [J].
Bray, M ;
Davis, K ;
Geisbert, T ;
Schmaljohn, C ;
Huggins, J .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :651-661
[10]   Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus [J].
Bray, M ;
Hatfill, S ;
Hensley, L ;
Huggins, JW .
JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) :243-253